abstract |
The present invention relates to a pharmaceutical composition comprising one or more pharmaceutically acceptable excipients and a prodrug neutralizing VEGF for use in a method of treating one or more ophthalmic disorders, said neutralizing VEGF Prodrugs contain biologically active radicals that neutralize VEGF. |